1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 968 F.Supp.2d
  5. 968 F.Supp.2d 1345 (2013)
 

IN RE INCRETIN MIMETICS PRODUCTS LIABILITY LIT.

MDL No. 2452.

968 F.Supp.2d 1345 (2013)

IN RE: INCRETIN MIMETICS PRODUCTS LIABILITY LITIGATION.

United States Judicial Panel on Multidistrict Litigation.

August 26, 2013.

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel: Pursuant to 28 U.S.C. § 1407, plaintiffs in two Southern District of California actions move to centralize this litigation, which involves four anti-diabetic medications that plaintiffs contend cause pancreatic cancer, in the Southern District of California. This litigation currently consists of 53 actions pending in seven districts, as listed on Schedule A.

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases